Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer
Titel:
Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer
Auteur:
Piccart, M.J. Bertelsen, K. Stuart, G. Cassidy, J. Mangioni, C. Simonsen, E. James, K. Kaye, S. Vergote, I. Blom, R. Grimshaw, R. Atkinson, R. Swenerton, K. Trope, C. Nardi, M. Kaern, J. Tumolo, S. Timmers, P. Roy, J.-A. Lhoas, F. Lidvall, B. Bacon, M. Birt, A. Andersen, J. Zee, B. Paul, J. Pecorelli, S. Baron, B. Mcguire, W.